I-European Commission imemezele izibuyekezo ku-Annex XVII ye-REACH Regulation enemikhawulo emisha ku-N,N-dimethylacetamide (DMAC) kanye ne-N-ethylpyrrolidone (NEP). Ithumele Isaziso G/TBT/N/EU/1079 ku-WTO ngomhla ka-Julayi 30, 2024. Lezi zinguquko zihlelelwe ukuthi ziqale ukusebenza ezinsukwini ezingu-20 ngemva kokushicilelwa ku-EU Official Journal.
I-Annex XVII ikhawulela ukusetshenziswa kwamakhemikhali athile ayingozi emakethe ye-EU. Ukufakwa kwe-DMAC ne-NEP kuzobeka lawa makhemikhali ekugadweni okuqinile kokulawula, ukuqinisekisa ukuthi yonke imikhiqizo equkethe, kungakhathaliseki ukuthi ikhiqizwa noma idayiswa e-EU, ihlangabezana nezindinganiso eziqinile zokuphepha ukuze kuvikelwe impilo kanye nemvelo.
Izibuyekezo eziqondile zimi kanje.
| Igama lomuthi | Inombolo ye-CAS./EC Cha. | Isilinganiso esivimbelayo |
| I-Dimethylacetamide (DMAC) | 127-19-5204-826-4 | Akumele ibekwe emakethe njengento iyodwa, njengengxenye yezinye izinto, noma izingxube ekuhlanganiseni okulingana noma okukhulu kuno-0.3 % ngemva [kosuku] ngaphandle kwalapho abakhiqizi, abangenisa kwamanye amazwe kanye nabasebenzisi abazansi nomfula befake emibikweni yokuphepha kwamakhemikhali nakumashidi wedatha yokuphepha, Amazinga Angenayo-Effect Atholakalayo (DNELs) ahlobene nokuchayeka 13 mg/noma isikhathi eside emsebenzini 3 mg/kg/ngosuku lokuchayeka esikhumbeni isikhathi eside.Ngeke yenziwe, noma isetshenziswe, njengento iyodwa, njengengxenye yezinye izinto, noma izingxube ekuhlanganiseni okulingana noma okukhulu kuno-0.53 % ngemva [kosuku olusesigabeni 0.3] ngaphandle kwalapho abakhiqizi nabasebenzisi abangaphansi komfula bethatha izinyathelo ezifanele zokulawula ubungozi futhi baqinisekise ukuthi zombili izisebenzi ezivezwayo zisebenza ngaphansi kwepharagrafu DNEL. 1. |
| I-1-ethyl-2-pyrrolidinon (NEP) | 2687-91-4220-250-6 | Akumele ibekwe emakethe njengento iyodwa, njengengxenye yezinye izinto, noma izingxube ekuhlanganiseni okulingana noma okukhulu kuno-0.3 % ngemva [kwedethi] ngaphandle kwalapho abakhiqizi, abangenisi kanye nabasebenzisi abasezansi nomfula befake emibikweni yokuphepha kwamakhemikhali kanye namashidi edatha yokuphepha, Amazinga Angenayo-Effect Atholakalayo (DNELs) ahlobene nokuchayeka kwe-4.0 mg/3 yesikhathi eside sezisebenzi. ukuchayeka okunamandla ngokuhogela kanye no-4.6 mg/kg/ngosuku ukuze utholakale esikhumbeni isikhathi eside. Angeke yenziwe, noma isetshenziswe, njengento ngokwayo, njengengxenye yezinye izinto, noma izingxube ekuhlanganiseni okulingana noma okukhulu kuno-2.4 % ngemva [ngosuku olusesigabeni 0.3] ngaphandle uma abakhiqizi kanye nezimo ezifanele zokulawula umfula bathatha izinyathelo ezifanele zokulawula umfula ukuze abasebenzi bathathe izinyathelo ezifanele zokulawula umfula. womabili ama-DNEL acaciswe esigabeni soku-1. |
Uma udinga noma yiluphi usizo noma unemibuzo, sicela uxhumane nathi nge-service@cirs-group.com.
Umthombo ovela CIRS
Ukuzihlangula: Ulwazi olubekwe ngenhla luhlinzekwa yi-cirs-group.com ngaphandle kwe-Chovm.com. I-Chovm.com ayenzi izethulo namawaranti mayelana nekhwalithi nokuthembeka komdayisi nemikhiqizo. I-Chovm.com iyazilahla ngokusobala noma yisiphi isibopho sokwephulwa kwelungelo lobunikazi lokuqukethwe.
